Tom Oxley

CEO, Synchron; Associate Professor and Head, Vascular Bionics Laboratory, of University of Melbourne; Director of Innovation Strategy, Department of Neurosurgery, Mount Sinai Health System

Tom Oxley is the founding CEO of Synchron, a brain data transfer company that is developing an implantable brain computer interface, Stentrode, which aims to provide a treatment for debilitating medical illnesses. A vascular and interventional neurologist and expert in brain computer interfaces, he is an associate professor and laboratory head of the University of Melbourne (Australia) Vascular Bionics Laboratory, as well as a clinical instructor in the neurosurgery department at Mount Sinai. Oxley’s background includes working on medtech start-ups and as a stroke neurologist at Royal Melbourne Hospital. He has performed over 1,600 endovascular neurosurgical procedures and published over 100 peer-reviewed articles in journals including Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine, and The Lancet.